hrp0098p3-119 | Fetal, Neonatal Endocrinology and Metabolism | ESPE2024

Experience with Octreotide-LAR in Hyperinsulinemic Hypoglycemia

Karagöz Kıymet , Liv Çanga Betül , Karacan Küçükali Gülin , Keskin Melikşah , Kurnaz Erdal , Aslı Bala Keziban , Savaş Erdeve Şenay

Introduction: Hyperinsulinemic hypoglycemia (HH) is characterized by inappropriate insulin secretion from pancreatic β-cells despite low blood glucose levels. The most common mutations causing HH affect the KATP channel genes [ABCC8 (36.8%) and KCNJ11 (5.9%)]. This report shares the experience of transitioning from daily subcutaneous octreotide to long-acting octreotide-LAR in a patient with HH due to a KATP channel mutation.<p class...

hrp0098p3-155 | Growth and Syndromes | ESPE2024

A Rare Cause of Short Stature in Boys: Lysineuric Protein Intolerance and Growth Hormone Experience

Bakır Gizem , Karagöz Kıymet , Kurnaz Erdal , Keskin Melikşah , Kılıç Musafa , Aslı Bala Keziban , Savaş Erdeve Şenay

Introduction: Lysineuric protein intolerance (LPI) is a rare autosomal recessive disorder caused by mutations in the SLC7A7 gene, which impairs the intestinal, renal and hepatic absorption of basic amino acids (lysine, arginine, ornithine). Children with LPI may present with protein avoidance, growth retardation, hepatosplenomegaly and osteoporosis. Here, we present two cases diagnosed with LPI due to short stature, with one case involving growth horm...

hrp0098p3-156 | Growth and Syndromes | ESPE2024

Growth Hormone Therapy in a Patient with Leri-Weill Dyschondrosteosis Presenting with Madelung Deformity

Karagöz Kıymet , Okur İclal , Keskin Melikşah , Kurnaz Erdal , Aslı Bala Keziban , Kolkıran Abdülkerim , Savaş Erdeve Şenay

Introduction: The SHOX (short stature homeobox) gene, located in the pseudoautosomal region of the X and Y chromosomes, implicated in Leri-Weill dyschondrosteosis, Langer mesomelic dysplasia, idiopathic short stature. Growth hormone (GH) therapy has proven effective in promoting height gain in patients with SHOX deficiency. We will present a case who was treated for borderline precocious puberty and diagnosed with Leri-Weill dyschondrosteosis upon adm...

hrp0095p1-26 | Bone, Growth Plate and Mineral Metabolism | ESPE2022

Outcomes of four patients with osteonecrosis after one-year pamidronate treatment

Yüksek Acinikli Kübra , Besci Özge , Yaşar Elif , Tüfekçi Özlem , Karadağ Zehra , Yıldız Gizem , Torun Rüya , Akın Kağızmanlı Gözde , Torun Bayram Meral , Yılmaz Şebnem , Güleryüz Handan , Abacı Ayhan , Böber Ece , Demir Korcan

Background: Osteonecrosis (ON) is bone death caused by inadequate blood supply resulting in demineralization and trabecular thinning and, subsequently, mechanical failure. Although the pathophysiology of ON is not fully understood, the use of high-dose glucocorticoid (GC) is one of the triggers. Furthermore, its optimal management remains uncertain. The use of bisphosphonates (BP) for the treatment of ON has been reported, however, data on outcomes are limited...

hrp0095p1-392 | Thyroid | ESPE2022

Clinical Features, Risk Classifications and Long-Term Follow Up Of Childhood Differentiated Thyroid Cancer(DTC): A Single Reference-Center Experience

Aycan Zehra , Çetin Sirmen Kızılcan , Zeynep Şıklar , Elif Özsu , Fitöz Suat , Ceyhan Koray , Yağmurlu Aydın , Göllü Bahadır Gülnur , Ünal Emel , Taşyıldız Nurdan , Kır Metin , Soydal Çiğdem , Berberoğlu Merih

Background: Thyroid cancers are rare in childhood. ATA guideline (Pediatric section) has been applied in daily practice since 2015. It is very significant to accurately predict the risk in the management of differentiated thyroid cancer(DTC). For this purpose, we shared our single center-20-year-experience about the follow-up features and management of childhood and adolescent thyroid cancer. We aimed to evaluate the dynamic risk stratification (DRS) and the o...

hrp0094fc1.6 | Adrenal | ESPE2021

Tumor DNA methylation profiling as a prognostic marker for pediatric patients with adrenocortical tumors

Bueno Ana Carolina , da Silva Rui M P , Stecchini Monica F. , Gutierrez Junier M , Cardinalli Izilda A , Scrideli Carlos A , Junqueira Thais , Molina Carlos A F , Ramalho Fernando S , Tucci Silvio , Coeli-Lacchini Fernanda B , Moreira Ayrton C , Ramalho Leandra N Z , Brandalise Silvia R , Yunes Jose A , de Castro Margaret , Vencio Ricardo Z N , Antonini Sonir R ,

Abnormal DNA methylation contributes to tumor progression and is emerging as a prognostic marker in several types of cancers. To investigate whether DNA methylation is associated with pediatric adrenocortical tumor (pACT) presentation and patient prognosis, we analyzed the methylation profile of 57 tumors (MethylationEPIC BeadChip Array-Illumina) and patientsÂ’ clinicopathological features and outcome. The study comprehended 40 girls and 17 boys, with median age at diagnos...

hrp0098p3-322 | Late Breaking | ESPE2024

Evaluation of Effects of Using Mobile Treatment Reminder GroConnect on Treatment Compliance and Treatment Response in Patients Receiving Growth Hormone Treatment – Preliminary Results

Çetinkaya Semra , Kandemir Tuğçe , Kızılay Özalp Deniz , Karagüzel Gülay , Türkkahraman Doğa , Eren Erdal , Yıldız Melek , Gül Uslu Nihal , Özen Samim , Ayça Cimbek Emine , Tıkız Ceyhun , Nursoy Hatice , Darendeliler Feyza

It is known that treatment reminder digital applications improve treatment compliance & response & healthcare expenses. Groconnect (mobile reminder) application is used by patients receiving growth hormone treatment (GHt), with its injection alarm/reminder/informative videos. Here, our three month preliminary data from our one-year follow-up study (aims to determine the effects of GroConnect use on treatment compliance & treatment response) is presented.<p clas...

hrp0095rfc9.2 | Pituitary, Neuroendocrinology and Puberty | ESPE2022

Investigation of Genes Associated with Multiple Pituitary Hormone Deficiencies via Next Generation Sequencing Technology

Pınar Öztürk Ayşe , Toksoy Güven , Baş Firdevs , Yavaş Abalı Zehra , Bagirova Gülendam , Karaman Volkan , Yıldız Melek , Aslanger Ayça , Yeşil Gözde , Poyrazoğlu Şükran , Oya Uyguner Zehra , Darendeliler Feyza

Background: Deficiency of one or more pituitary hormones, often with growth hormone (GH) deficiency, is defined as multiple pituitary hormone deficiencies (MPHD) or congenital hypopituitarism (CH). CH cases are mostly sporadic and have a prevalence of 1/3000-4000 live births. There are many known and yet unknown molecular pathways explaining the complex structure and functions of the pituitary gland. Many different gross and small sequence variants in the gene...

hrp0092rfc7.5 | Diabetes and Insulin Session 2 | ESPE2019

Dual Diagnosis of Type 1 Diabetes and ADHD

Mazor-Aronovitch Kineret , Pinhas-Hamiel Orit , Modan-Moses Dalit , Levek Noah , Pivko-Levy Dikla , Miller Shahar , Graph-Barel Chana , Frumkin Ben-David Rachel , Ben-Ami Michal , Stern Eve Z , Gruber Noah , Levy-Shraga Yael , Landau Zohar

Background: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. Type 1 diabetes (T1DM) is the most common metabolic disease in children. The treatment of T1DM requires high executive functions and requires very intensive treatment that could be an obstacle for patients with ADHD. Dual diagnosis of T1DM and ADHD might affect treatment, control and complications of T1DM. In order to prevent long-term complica...

hrp0092p1-31 | Diabetes and Insulin | ESPE2019

Dual Diagnosis of Type 1 Diabetes and ADHD

Mazor-Aronovitch Kineret , Pinhas-Hamiel Orit , Modan-Moses Dalit , Levek Noah , Pivko-Levy Dikla , Miller Shahar , Graph-Barel Chana , Ben-David Rachel Frumkin , Ben-Ami Michal , Stern Eve Z , Gruber Noah , Levy-Shraga Yael , Landau Zohar

Background: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. Type 1 diabetes (T1DM) is the most common metabolic disease in children. The treatment of T1DM requires high executive functions and requires very intensive treatment that could be an obstacle for patients with ADHD. Dual diagnosis of T1DM and ADHD might affect treatment, control and complications of T1DM. In order to prevent long-term complica...